Delivery Order SPE2DB22D1017-SPE2DB24FF0UG
Award Date 1/4/24
Potential Completion Date 1/5/24
Potential Value $3.7K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply TIVICAY 50 MG TABLET 30S pharmaceuticals. The $6,667.38 contract has a completion date of January 18, 2024. This order is part of Amerisourcebergen's broader indefinite delivery contract with DLA to provide pharmaceuticals and medical supplies in support of military treatment programs and facilities. No set-aside...
- This is a $27,890.73 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of TIVICAY 50 MG TABLET 30S. The contract has a period of performance through July 31, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was awarded this delivery order as part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TIVICAY 50 MG TABLET 30S. The award has a potential value of $4,025.74 and a period of performance through February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside was used for this contract. This delivery order is issued under an indefinite delivery contract (IDC) held by...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of TIVICAY 50 MG TABLET 30S, with a potential value of $2,496.14 and a completion date of January 16, 2024. The contract has no set-aside designation. Amerisourcebergen Drug Corp has received numerous...
- This is a $18,626.12 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TIVICAY 50 MG TABLET 30S. The contract has an ultimate completion date of July 7, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,774,951 units of the pharmaceutical product TIVICAY 50 MG TABLET 30S. The $1,796.61 contract has a completion date of February 27, 2024 and was awarded on February 26, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and will deliver the medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $35,517.35 firm fixed-price contract is for the supply of the pharmaceutical product TIVICAY 50 MG TABLET 30S. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the...
- This is a $3,744.21 firm fixed price delivery order contract awarded by the U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the delivery of TIVICAY 50 MG TABLET 30S, a pharmaceutical product, with a period of performance through April 16, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the federal government, including the Department of...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TIVICAY 50 MG TABLET 30S. The contract has a potential value of $4,084.15 and a performance period through March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor on this contract, which does not have a set-aside designation. The contract is part of a larger indefinite delivery contract...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of TIVICAY 50 MG TABLET 30S. The $1,248.07 order is for the delivery of this pharmaceutical product to support DLA Troop Support Medical programs and facilities. No set-aside designation was used for this contract. AmerisourceBergen Drug Corp is a prime contractor that has received numerous federal contract awards...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF0UGDelivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TIVICAY 50 MG TABLET 30S. The $3,744.21 contract has a completion date of January 5, 2024. As a prime contractor, Amerisourcebergen Drug Corp has a history of providing pharmaceutical products and medical supplies to support DLA Troop Support Medical programs. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp's parent company, Cencora, Inc., also does business as Amerisourcebergen.
Generated 4/4/24, 10:12 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 1/4/24 |